Effects of non-invasive ventilation and highflow nasal cannula in acute high altitude pulmonary edema with respiratory failure

Effects of non-invasive ventilation and highflow nasal cannula in acute high altitude pulmonary edema with respiratory failure: A randomized controled trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200061947

Enrollment

Unknown

Registered

2022-07-13

Start date

2022-08-01

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute high altitude pulmonary edema

Interventions

Group 1 :non-invasive ventilation

Group 2:highflow nasal cannula oxygen

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-70 years old, regardless of sex; 2. Patients with acute high altitude pulmonary edema who meet the "Nomenclature, Classification and Diagnostic Criteria of High Altitude Disease in China" formulated by the Third National Symposium on High Altitude Medicine of Chinese Medical Association.

Exclusion criteria

Exclusion criteria: 1. Patients with respiratory and cardiac arrest; 2. Those with vomiting symptoms; those with weak spontaneous breathing, coma, and disturbance of consciousness; 3. Facial trauma, deformity and other similar conditions; 4. There are more viscous respiratory secretions; 5. Those with hypotension; 6. Other researchers think that it is not suitable to participate in the experiment.

Design outcomes

Primary

Measure	Time frame
pressure of aterial oxygen over fraction of insprired oxygen;	—

Secondary

Measure	Time frame
vital signs;comfort score;	—

Countries

China

Contacts

Public ContactHangyong He

Beijing Chaoyang Hospital

yonghang2004@sina.com+86 13693585722

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026